David Henderson

David Henderson is an experienced executive in the life sciences and technology industries with over 30 years of commercial, financial, and general management experience.1 He served as Vice President of Global Commercial Operations at BioMarin Pharmaceutical Inc. from January 2018 to July 2021.1 In this role, he was responsible for a wide range of commercial functions including global revenue planning and analytics, launch sequencing, price management, commercial systems, and US managed markets and trade.1

Prior to his position as Vice President, Henderson held the role of Executive Director of Global Commercial Operations at BioMarin from August 2014 to January 2018.1 His career also includes leadership positions at other companies:

• CEO and CFO at The FRS Company (2008-2013)1
• Chief Financial Officer at Genentech Foundation for BioMedical Sciences (2007-2008)1
• Various roles at companies like Oracle, PeopleSoft, CommerceOne, and Morgan Stanley & Company (1992-2002)1

Henderson holds a BS in Business Administration from the University of California, Berkeley, and an MBA from the JL Kellogg School of Management at Northwestern University.1 He also earned a certificate in Biotechnology for Business from Duke University.1

Currently, Henderson is a Co-Founder and Partner at A3Access Advisors, LLC, a company he started in August 2023.12 A3Access Advisors focuses on ensuring that innovative medicines have fully integrated commercial and market access strategies to accelerate market adoption and commercial success.1

Throughout his career, Henderson has developed expertise in various areas of the pharmaceutical industry, including:

• Pricing strategies for chronic therapies and gene therapies1
• Product life-cycle management from pipeline to launch, growth, and maturity1
• Working with distribution partners, including specialty pharmacies and wholesalers1
• Supporting therapies in rare diseases, oncology, immunology, and ophthalmology1